5.60
Precedente Chiudi:
$5.36
Aprire:
$5.37
Volume 24 ore:
303.00K
Relative Volume:
0.32
Capitalizzazione di mercato:
$193.35M
Reddito:
$59.63M
Utile/perdita netta:
$-72.21M
Rapporto P/E:
-2.6667
EPS:
-2.1
Flusso di cassa netto:
$-30.85M
1 W Prestazione:
+3.51%
1M Prestazione:
+43.59%
6M Prestazione:
+61.85%
1 anno Prestazione:
-1.23%
908 Devices Inc Stock (MASS) Company Profile
Nome
908 Devices Inc
Settore
Industria
Telefono
978-729-4478
Indirizzo
645 SUMMER STREET, BOSTON
Confronta MASS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MASS
908 Devices Inc
|
5.60 | 193.35M | 59.63M | -72.21M | -30.85M | -2.10 |
![]()
ABT
Abbott Laboratories
|
132.82 | 223.47B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.93 | 150.72B | 17.55B | 2.03B | 2.37B | 1.37 |
![]()
SYK
Stryker Corp
|
378.22 | 139.34B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.85 | 107.15B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.65 | 44.54B | 5.54B | 4.18B | 259.90M | 7.00 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
2023-02-07 | Iniziato | Stephens | Overweight |
2021-10-15 | Ripresa | Cowen | Outperform |
2021-01-12 | Iniziato | Cowen | Outperform |
2021-01-12 | Iniziato | SVB Leerink | Outperform |
2021-01-12 | Iniziato | Stifel | Buy |
2021-01-12 | Iniziato | William Blair | Outperform |
Mostra tutto
908 Devices Inc Borsa (MASS) Ultime notizie
LPL Financial LLC Grows Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
Geode Capital Management LLC Raises Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection - 01net
Why 908 Devices Inc. (MASS) is Surging in 2025 - Insider Monkey
XTX Topco Ltd Buys Shares of 52,196 908 Devices Inc. (NASDAQ:MASS) - Defense World
Repligen Corporation Q1 2025 Financial Results - TradingView
908 Devices receives $2M order from the Texas Department of Public Safety for drug detection and mitigation - Police1
908 Devices (NASDAQ:MASS) Receives “Sell (D-)” Rating from Weiss Ratings - Defense World
Market Insights: 908 Devices Inc (MASS)’s Notable Drop of -4.59, Closing at 5.40 - DWinneX
MASS’s Market Whiplash: 157.27% YTD Rise, 24.94% Rise in 30 Days - investchronicle.com
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue - Yahoo Finance
908 Devices Inc. Receives $2 Million Order from the Texas Department of Public Safety for Drug Detection and Mitigation - marketscreener.com
Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed - Nasdaq
CRISPR Therapeutics AG (CRSP) Is A Buy According To Analysts - Marketing Sentinel
MASS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
908 Devices Gets $2 Million Order From Texas for Drug Detection Tools - marketscreener.com
908 Devices (MASS) Secures $2M Order from Texas Department of Pu - GuruFocus
908 Devices rises after $2 million order from Texas Department of Public Safety - TradingView
908 Devices (MASS) Secures $2M Order from Texas Department of Public Safety | MASS Stock News - GuruFocus
908 Devices Receives $2M Order From The Texas Department Of Public Safety For Drug Detection And Mitigation - marketscreener.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation | MASS Stock News - GuruFocus
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - Business Wire
908 Devices Inc. - firehouse.com
Stifel maintains Buy on 908 Devices, price target steady at $6 - Investing.com Canada
908 Devices reports 55% revenue jump in Q1 By Investing.com - Investing.com South Africa
908 Devices Announces Preliminary First Quarter 2025 Financial Results - BioSpace
908 Devices expects Q1 revenue below estimates - MSN
908 Devices reports preliminary Q1 revenue $11.5M. consensus $11.9M - TipRanks
908 Devices Announces Preliminary First Quarter 2025 Financial R - GuruFocus
908 Devices Announces Preliminary Q1 2025 Financial Results - marketscreener.com
908 Devices reports 55% revenue jump in Q1 - Investing.com
908 Devices Surges with 55% Growth: Q1 Revenue Hits $11.5M After Strategic Portfolio Shift - Stock Titan
Prudential Financial Inc. Makes New Investment in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Leads These 3 Penny Stocks To Consider - Yahoo Finance
908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP - TradingView
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
Best Momentum Stocks to Buy for March 13th - Yahoo Finance
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc Azioni (MASS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):